Original Research Article
Year: 2020 | Month: July | Volume: 10 | Issue: 7 | Pages: 191-197
Role of Comprehensive Diabetes Care in Known Diabetes Patients from Karnataka Region
Rohit Sane1, Rahul Mandole2, Gurudatta Anand Amin3, Pravin Ghadigaokar4, Sneha Paranjape5, Prasad Deshpande6
1Managing Director, MD, Madhavbaug Cardiac Hospitals and Clinics, India.
2Head of Department of Research & Development, Madhavbaug Cardiac Clinic and Hospital, Thane, Maharashtra, India.
3Chief Medical Officer, Madhavbaug Cardiac Clinic and Hospital, Thane, Maharashtra, India.
4Head Medical Operations, Madhavbaug Cardiac Clinic and Hospital, Thane, Maharashtra, India.
5Chief Dietitian, Madhavbaug Cardiac Clinic and Hospital, Mumbai, Maharashtra, India.
6Regional Head, Karnataka Region, Madhavbaug Cardiac Clinic and Hospital, Karnataka, Maharashtra, India.
Corresponding Author: Rahul Mandole
ABSTRACT
Introduction: Globally, multiple million of the population is suffering from diabetes mellitus (DM), which follows chronic course. The prevalence of DM in Karnataka has been reported to be as high as 12%. Comprehensive diabetes care program (CDC) is an Ayurvedic form of therapy which consists of management of T2DM by Panchkarma, diet therapy.
Aims and objectives: The present study was planned to analyze the effectiveness of CDC on blood glucose, physical and cardiorespiratory parameters in patient of T2DM.
Materials and methods: This observational study was conducted from November 2018 to October 2019, wherein the data of type 2 DM patients (HbA1c >6.6%) who attended out-patient departments (OPDs) at Madhavbaug clinics across Karnataka were identified. Data of patients who were administered CDC over 12 weeks were considered. All the glycemic parameters were compared at baseline and week 12.
Results: In the present study, out of 35 patients the number of patients with controlled DM status rose from zero at baseline to 17 (48%) at week 12 of CDC therapy. Mean HbA1c levels were reduced from 9.01 at baseline to 7.36 at week 12 (p=0.001). All the anthropometric parameters, lipid parameters, etc., showed statistically significant improvement, and reduction in dependency on allopathic medications at week 12 of CDC therapy.
Conclusion: From the findings of the present study, it was clear that CDC improved two most critical parameters- reduction in HbA1c and patient’s dependency on conventional medicines, which helps to reduce cost of therapy and thus improve patient compliance.
Key words: DM, Comprehensive Diabetes Care, CDC, panchkarma, glycosylated HB, HbA1C.